Company / Current Liabilities per Share
MADRIGAL PHARMACEUTICALS, INC. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$14.10
FY2025
5-year range
$4.95 / $14.10
FY2021-FY2025
Trend
+65.6%
vs FY2024
Sector context
#12 of 210
Health Care
What the data says
Among 210 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the bottom 6% for current liabilities per share. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.57 in FY2018 to $14.10 in FY2025.
Based on SEC 10-K filings.
14.10 in FY2025 with a 5-year CAGR of +36.1%. Top quartile in the Health Care sector.
Increased from $6.55 to $14.10 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +27.8%
- 5-Year CAGR
- +36.1%
- 10-Year CAGR
- -
Sector benchmark
-40.7% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 65.6% year-over-year.
- Ranks #12 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.10 | +65.6% |
| FY2024 | $8.52 | +30.1% |
| FY2023 | $6.55 | -3.2% |
| FY2022 | $6.76 | +36.5% |
| FY2021 | $4.95 | +64.2% |
| FY2020 | $3.02 | +84.9% |
| FY2019 | $1.63 | +186.0% |
| FY2018 | $0.57 | -30.5% |
| FY2017 | $0.82 | -11.0% |
| FY2016 | $0.92 | +154.5% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026